Published in Prostaglandins Leukot Essent Fatty Acids on November 08, 2012
The Marine-Derived Fungus Clonostachys rosea, Source of a Rare Conjugated 4-Me-6E,8E-hexadecadienoic Acid Reducing Viability of MCF-7 Breast Cancer Cells and Gene Expression of Lipogenic Enzymes. Mar Drugs (2015) 0.78
The selective target of capsaicin on FASN expression and de novo fatty acid synthesis mediated through ROS generation triggers apoptosis in HepG2 cells. PLoS One (2014) 0.76
The effects of conjugated linoleic acids on breast cancer: A systematic review. Adv Biomed Res (2016) 0.75
SREBP-1 is an independent prognostic marker and promotes invasion and migration in breast cancer. Oncol Lett (2016) 0.75
Differential regulation of the MAP, SAP and RK/p38 kinases by Pyst1, a novel cytosolic dual-specificity phosphatase. EMBO J (1996) 2.59
Inactivation of the protein phosphatase 2A regulatory subunit A results in morphological and transcriptional defects in Saccharomyces cerevisiae. Mol Cell Biol (1992) 2.33
Lymphangitis carcinomatosa: a literature review. J R Coll Surg Edinb (1996) 2.00
Positron emission tomography using [(18)F]-fluorodeoxy-D-glucose to predict the pathologic response of breast cancer to primary chemotherapy. J Clin Oncol (2000) 1.69
Complementary and alternative medicines use by Scottish women with breast cancer. What, why and the potential for drug interactions? Eur J Clin Pharmacol (2011) 1.62
Surgical management of the septic complications of diverticular disease. Ann R Coll Surg Engl (1995) 1.44
Peri-operative acute phase response and cytokine releasein women with breast cancer: modulation bypolyadenylic-polyuridylic acid. Eur J Surg Oncol (1999) 1.41
Natural killer cells and cancer. Cancer (1996) 1.33
Cognitive performance and mood after a weekend on call in a surgical unit. Br J Surg (1997) 1.30
The accuracy of "one-stop" diagnosis for 1,110 patients presenting to a symptomatic breast clinic. J R Coll Surg Edinb (1999) 1.11
XCL100, an inducible nuclear MAP kinase phosphatase from Xenopus laevis: its role in MAP kinase inactivation in differentiated cells and its expression during early development. J Cell Sci (1995) 1.11
Breast cancer in women aged 35 and under: prognosis and survival. J R Coll Surg Edinb (2002) 1.09
Clenbuterol, a beta-adrenoceptor agonist, increases relative muscle strength in orthopaedic patients. Clin Sci (Lond) (1993) 1.08
Measurement of albumin synthesis in humans: a new approach employing stable isotopes. Am J Physiol (1990) 1.05
Psychological, clinical and pathological effects of relaxation training and guided imagery during primary chemotherapy. Br J Cancer (1999) 1.02
A regulated MET3-GLC7 gene fusion provides evidence of a mitotic role for Saccharomyces cerevisiae protein phosphatase 1. Yeast (1995) 1.02
Alterations in polyamine catabolic enzymes in human breast cancer tissue. Clin Cancer Res (2000) 1.01
Effect of CLA supplementation on immune function in young healthy volunteers. Eur J Clin Nutr (2005) 1.00
Folate and breast cancer: the role of polymorphisms in methylenetetrahydrofolate reductase (MTHFR). Cancer Lett (2002) 1.00
Interleukin 2 therapy in cancer: identification of responders. Br J Cancer (1992) 1.00
The use of FDG-PET in assessing axillary lymph node status in breast cancer: a systematic review and meta-analysis of the literature. Breast Cancer Res Treat (2010) 1.00
Impact of manipulations of myogenesis in utero on the performance of adult skeletal muscle. Reproduction (2001) 0.99
Carcinoid tumour of the gall bladder: two case reports and a review of published works. Gut (1993) 0.98
Haemangiopericytoma of the greater omentum. Eur J Surg Oncol (1995) 0.97
Treatment of large and locally advanced breast cancers using neoadjuvant chemotherapy. Am J Surg (1998) 0.97
Correlation of serum cytokine and acute phase reactant levels with alterations in weight and serum albumin in patients receiving immunotherapy with recombinant IL-2. Clin Exp Immunol (1994) 0.92
Interleukin 2 receptor expression and interleukin 2 localisation in human solid tumor cells in situ and in vitro: evidence for a direct role in the regulation of tumour cell proliferation. Int J Cancer (1995) 0.91
Staging of the axilla in breast cancer: accurate in vivo assessment using positron emission tomography with 2-(fluorine-18)-fluoro-2-deoxy-D-glucose. Ann Surg (1998) 0.91
Psychological factors can predict the response to primary chemotherapy in patients with locally advanced breast cancer. Eur J Cancer (1999) 0.91
Chronic preoperative pain and psychological robustness predict acute postoperative pain outcomes after surgery for breast cancer. Br J Cancer (2012) 0.91
Baseline MRI delivery characteristics predict change in invasive ductal breast carcinoma PET metabolism as a result of primary chemotherapy administration. Ann Oncol (2006) 0.90
Minimal modulation of lymphocyte and natural killer cell subsets following minimal access surgery. Am J Surg (1999) 0.90
Regulation of adhesion molecule expression in human endothelial and smooth muscle cells by omega-3 fatty acids and conjugated linoleic acids: involvement of the transcription factor NF-kappaB? Prostaglandins Leukot Essent Fatty Acids (2007) 0.90
What is achieved by mammographic surveillance after breast conservation treatment for breast cancer? Am J Surg (2001) 0.90
Stimulation of human breast cancers by dietary L-arginine. Clin Sci (Lond) (1992) 0.89
Distal procto-colitis and n-3 polyunsaturated fatty acids: the mechanism(s) of natural cytotoxicity inhibition. Eur J Clin Invest (2000) 0.89
Femoral hernia: mortality and morbidity following elective and emergency surgery. J R Coll Surg Edinb (1991) 0.89
Distal procto-colitis, natural cytotoxicity, and essential fatty acids. Am J Gastroenterol (1998) 0.87
Immune suppression and isolated severe head injury: a significant clinical problem. Br J Neurosurg (2003) 0.86
Measurement of protein synthesis in human skeletal muscle: further investigation of the flooding technique. Clin Sci (Lond) (1991) 0.86
Polyadenylic-polyuridylic acid enhances the natural cell-mediated cytotoxicity in patients with breast cancer undergoing mastectomy. Surgery (1995) 0.85
Tumour and host tissue responses to branched-chain amino acid supplementation of patients with cancer. Clin Sci (Lond) (1994) 0.85
Synthetic polyribonucleotides: current role and potential use in oncological practice. Eur J Surg Oncol (1995) 0.84
Interleukin-2 (IL-2) augments host cellular immune reactivity in the perioperative period in patients with malignant disease. Eur J Surg Oncol (1995) 0.84
The psychological and psychiatric effects of rIL-2 therapy: a controlled clinical trial. Psychooncology (1997) 0.84
Reversal of Hartmann's colostomy. J R Coll Surg Edinb (1994) 0.83
Moving inwards, moving outwards, moving upwards: the role of spirituality during the early stages of breast cancer. Eur J Cancer Care (Engl) (2011) 0.83
Modulation in vitro of human natural cytotoxicity, lymphocyte proliferative response to mitogens and cytokine production by essential fatty acids. Immunology (1997) 0.83
Omega-3 N-acylethanolamines are endogenously synthesised from omega-3 fatty acids in different human prostate and breast cancer cell lines. Prostaglandins Leukot Essent Fatty Acids (2011) 0.82
Nutrition and the surgical patient: triumphs and challenges. Surgeon (2005) 0.82
Acute phase proteins and recombinant IL-2 therapy: prediction of response and survival in patients with colorectal cancer. Clin Exp Immunol (1995) 0.82
Fatty acids and prostate cancer: current status and future challenges. J R Coll Surg Edinb (1999) 0.82
Coenzyme Q differentially modulates phospholipid hydroperoxide glutathione peroxidase gene expression and free radicals production in malignant and non-malignant prostate cells. Biofactors (2003) 0.82
The cognitive effects of recombinant interleukin-2 (rIL-2) therapy: a controlled clinical trial using computerised assessments. Eur J Cancer (1996) 0.82
L-arginine stimulates host defenses in patients with breast cancer. Surgery (1994) 0.82
Freehand core biopsy in breast cancer: an accurate predictor of tumour grade following neoadjuvant chemotherapy? Breast (2002) 0.82
Impaired expression of glutathione peroxidase-4 gene in peripheral blood mononuclear cells: a biomarker of increased breast cancer risk. Cancer Biomark (2010) 0.82
Effects of conjugated linoleic acid plus n-3 polyunsaturated fatty acids on insulin secretion and estimated insulin sensitivity in men. Eur J Clin Nutr (2008) 0.82
Nutritional pharmacology: effects of L-arginine on host defences, response to trauma and tumour growth. Clin Sci (Lond) (1994) 0.81
L-arginine and malignant disease: a potential therapeutic role? Eur J Surg Oncol (1994) 0.81
Biomarkers of oxidative stress in schizophrenic and control subjects. Prostaglandins Leukot Essent Fatty Acids (2007) 0.81
Apoptosis and prognosis in cancer: rationale and relevance. J R Coll Surg Edinb (2000) 0.80
Cancer cachexia: pathophysiological mechanisms. Eur J Surg Oncol (1996) 0.80
In vivo cytokine production and recombinant interleukin 2 immunotherapy: an insight into the possible mechanisms underlying clinical responses. Br J Cancer (1994) 0.80
Organ-specific measurements of protein turnover in man. Proc Nutr Soc (1991) 0.80
Male breast cancer: clinico-pathological features, immunocytochemical characteristics and prognosis. Eur J Surg Oncol (1996) 0.79
Cell signal mechanisms, conjugated linoleic acids (CLAs) and anti-tumorigenesis. Prostaglandins Leukot Essent Fatty Acids (2002) 0.79
Dietary supplementation with L-arginine in patients with breast cancer (> 4 cm) receiving multimodality treatment: report of a feasibility study. Br J Cancer (1994) 0.79
Immunonutrition in clinical practice: what is the current evidence? Nutr Hosp (2005) 0.78
Renal function in rats treated with cyclosporin following unilateral nephrectomy. Br J Exp Pathol (1985) 0.78
Effect of essential fatty acids on circulating T cell subsets in patients with colorectal cancer. Cancer Immunol Immunother (1994) 0.78
Modulation of cytokine production in vivo by dietary essential fatty acids in patients with colorectal cancer. Clin Sci (Lond) (1994) 0.78
Superimposition of PET images using 18F-fluorodeoxyglucose with magnetic resonance images in patients with pancreatic carcinoma. Nucl Med Commun (1995) 0.78
Arginine metabolism in benign and malignant disease of breast and colon: evidence for possible inhibition of tumor-infiltrating macrophages. Nutrition (1992) 0.78
Distal proctocolitis and n-3 polyunsaturated fatty acids (n-3 PUFAs): the mucosal effect in situ. J Clin Immunol (2000) 0.78
Fatty acid regulation of protein kinase C isoforms in prostate cancer cells. Biochem Biophys Res Commun (2001) 0.78
A novel diagnostic index for use in the breast clinic. J R Coll Surg Edinb (1996) 0.78
Minimal access surgery for cholelithiasis induces an attenuated acute phase response. Am J Surg (1999) 0.78
Current and potential chemotherapeutic agents used for induction chemotherapy in the treatment of breast cancer. Curr Pharm Des (2000) 0.78
Psychosocial aspects of cancer in the elderly. Eur J Surg Oncol (1998) 0.77
Genetic analyses of yeast protein serine/threonine phosphatases. FEMS Microbiol Lett (1994) 0.77
Immunonutrition. Br J Surg (2003) 0.77
Evidence for Fas counter attack in vivo from a study of colorectal cancer. Oncol Rep (2000) 0.77
Natural cytotoxicity in breast cancer patients receiving neoadjuvant chemotherapy: effects of L-arginine supplementation. Eur J Surg Oncol (1994) 0.77
Immunopathological changes in the skin following recombinant interleukin-2 treatment. J Pathol (1992) 0.77
Recombinant interleukin-2 treatment in patients with metastatic colorectal cancer: effect on natural cytotoxicity. Cancer Immunol Immunother (1992) 0.77
The biological correlates of macroscopic breast tumour structure measured using fractal analysis in patients undergoing neoadjuvant chemotherapy. Breast Cancer Res Treat (2012) 0.77
Modulation of the cytokine and acute-phase response to major surgery by recombinant interleukin-2. Br J Surg (1995) 0.77
Expression of growth factor receptors is not a prognostic indicator in young patients with colorectal cancer. J R Coll Surg Edinb (1997) 0.76
Alleviation of experimental cyclosporin A nephrotoxicity by low dose aspirin in the rat. Biochem Pharmacol (1993) 0.76
Immunohistochemical detection of a germline BRCA1 mutation in a breast and ovarian cancer family. Breast (2000) 0.76
Positron emission tomography: 2-deoxy-2-[18F]-fluoro-D-glucose uptake in locally advanced breast cancers. Eur J Surg Oncol (1995) 0.75
Pattern of 2-deoxy-2-[18F]-fluro-D-glucose accumulation in liver tumours: primary, metastatic and after chemotherapy. Nucl Med Commun (1992) 0.75